Which of the following fluoroquinolones does not require dose adjustment in a patient with creatinine clearance of < 50mg/min –
## **Core Concept**
Fluoroquinolones are a class of antibiotics that are primarily excreted by the kidneys. In patients with renal impairment, dose adjustment of these drugs is often necessary to prevent accumulation and potential toxicity. The degree of renal excretion varies among different fluoroquinolones.
## **Why the Correct Answer is Right**
Moxifloxacin is unique among fluoroquinolones because it undergoes extensive hepatic metabolism and biliary excretion, with only a small fraction of the drug being excreted unchanged in the urine. This pharmacokinetic profile means that renal impairment has a minimal effect on its plasma concentrations, and thus, dose adjustment is not required in patients with reduced creatinine clearance.
## **Why Each Wrong Option is Incorrect**
- **Option A:** Ciprofloxacin is primarily excreted by the kidneys, and its clearance is significantly reduced in patients with renal impairment. Dose adjustment is recommended for patients with a creatinine clearance of <50 mL/min to avoid toxicity.
- **Option B:** Levofloxacin is also mainly excreted by the kidneys. Its dose needs to be adjusted in patients with renal impairment to prevent accumulation and potential adverse effects.
- **Option D:** Ofloxacin is excreted primarily by the kidneys as well. Dose adjustment is necessary in patients with reduced renal function to avoid excessive drug levels.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Moxifloxacin stands out among fluoroquinolones for not requiring dose adjustment in renal impairment, making it a preferable option in patients with renal issues. This is crucial for managing patients with complicated infections and concurrent renal impairment.
## **Correct Answer:** C. Moxifloxacin.